Study: Half of confirmatory studies for accelerated approvals are late

Regulatory News

Regulatory NewsJoanne S. Eglovitch

Biologics/ biosimilars/ vaccinesClinical TrialsComplianceNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy